Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released

• Published in: Blood 2008-02, Vol.111 (3), p.1227-1233
• Main Authors: Italiano, Joseph E., Richardson, Jennifer L., Patel-Hett, Sunita, Battinelli, Elisabeth, Zaslavsky, Alexander, Short, Sarah, Ryeom, Sandra, Folkman, Judah, Klement, Giannoula L.
• Format: Article
• Language: English
• Subjects: Blood Platelets - metabolism; Blood Platelets - ultrastructure; Hemostasis, Thrombosis, and Vascular Biology; Humans; Intracellular Membranes - metabolism; Intracellular Membranes - ultrastructure; Microscopy, Immunoelectron; Neovascularization, Physiologic; Peptide Hydrolases - metabolism
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2007-09-113837

Platelets, in addition to their function in hemostasis, play an important role in wound healing and tumor growth. Because platelets contain angiogenesis stimulators and inhibitors, the mechanisms by which platelets regulate angiogenesis remain unclear. As platelets adhere to activated endothelium, their action can enhance or inhibit local angiogenesis. We therefore suspected a higher organization of angiogenesis regulators in platelets. Using double immunofluorescence and immunoelectron microscopy, we show that pro- and antiangiogenic proteins are separated in distinct subpopulations of α-granules in platelets and megakaryocytes. Double immunofluorescence labeling of vascular endothelial growth factor (VEGF) (an angiogenesis stimulator) and endostatin (an angiogenesis inhibitor), or for thrombospondin-1 and basic fibroblast growth factor, confirms the segregation of stimulators and inhibitors into separate and distinct α-granules. These observations motivated the hypothesis that distinct populations of α-granules could undergo selective release. The treatment of human platelets with a selective PAR4 agonist (AYPGKF-NH2) resulted in release of endostatin-containing granules, but not VEGF-containing granules, whereas the selective PAR1 agonist (TFLLR-NH2) liberated VEGF, but not endostatin-containing granules. In conclusion, the separate packaging of angiogenesis regulators into pharmacologically and morphologically distinct populations of α-granules in megakaryocytes and platelets may provide a mechanism by which platelets can locally stimulate or inhibit angiogenesis.